Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia

Hagop M. Kantarjian, Moshe Talpaz, Susan O'Brien, Francis Giles, Guillermo Garcia-Manero, Stefan Faded, Deborah Thomas, Jianqin Shan, Mary Beth Rios, Jorge Cortes

Research output: Contribution to journal › Article › peer-review